Sinus surgery is a pillar of CRS with nasal polyps treatment, but how do the safety risks compare to those of biologic therapy? Experts in the field explain how they identify which patients are better suited for DUPIXENT than surgery and why “none of us should feel threatened by the option of a nonsurgical treatment” like DUPIXENT.